KRAS and neoplasm: We identified 104 (47%) tumors with KRAS mutations, including one tumor with three KRAS p.G12C, p.G12V, and pG13C mutations and six tumors with two KRAS mutations p.G12V and p.G15S; pG12S and p.G12V; p.G12D and p.V9F; p.G12S and p.A59E; p.G12D and p.T58I; p.G12C and p.G13D.